Stryker Corporation
Stryker Corporation operates as a medical technology company in the United States and internationally. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics. The MedSurg and Neurotechnology segment offers surgical equipment, patient and caregiver safety technologies, navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment … Read more
Market Cap & Net Worth: Stryker Corporation (SYK)
Stryker Corporation (NYSE:SYK) has a market capitalization of $133.77 Billion ($133.77 Billion) as of March 18, 2026. Listed on the NYSE stock exchange, this USA-based company holds position #153 globally and #121 in its home market, demonstrating a -4.11% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Stryker Corporation's stock price $349.56 by its total outstanding shares 382688675 (382.69 Million).
Stryker Corporation Market Cap History: 2015 to 2026
Stryker Corporation's market capitalization history from 2015 to 2026. Data shows growth from $32.16 Billion to $133.77 Billion (13.86% CAGR).
Index Memberships
Stryker Corporation is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
S&P 500 Index
GSPC
|
$53.10 Trillion | 0.27% | #81 of 503 |
Weight: Stryker Corporation's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Stryker Corporation Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Stryker Corporation's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
5.36x
Stryker Corporation's market cap is 5.36 times its annual revenue
0.67x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
41.44x
Stryker Corporation's market cap is 41.44 times its annual earnings
1.97x
Higher than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $42.04 Billion | $11.32 Billion | $1.65 Billion | 3.71x | 25.52x |
| 2017 | $55.00 Billion | $12.44 Billion | $1.02 Billion | 4.42x | 53.92x |
| 2018 | $56.34 Billion | $13.60 Billion | $3.55 Billion | 4.14x | 15.86x |
| 2019 | $76.24 Billion | $14.88 Billion | $2.08 Billion | 5.12x | 36.60x |
| 2020 | $90.09 Billion | $14.35 Billion | $1.60 Billion | 6.28x | 56.34x |
| 2021 | $99.30 Billion | $17.11 Billion | $1.99 Billion | 5.80x | 49.80x |
| 2022 | $91.94 Billion | $18.45 Billion | $2.36 Billion | 4.98x | 38.99x |
| 2023 | $113.82 Billion | $20.50 Billion | $3.17 Billion | 5.55x | 35.96x |
| 2024 | $137.79 Billion | $22.59 Billion | $2.99 Billion | 6.10x | 46.04x |
| 2025 | $134.50 Billion | $25.12 Billion | $3.25 Billion | 5.36x | 41.44x |
Competitor Companies of SYK by Market Capitalization
Companies near Stryker Corporation in the global market cap rankings as of March 18, 2026.
Key companies related to Stryker Corporation by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #79 globally with a market cap of $190.05 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #169 globally with a market cap of $112.92 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #191 globally with a market cap of $103.18 Billion USD.
- Edwards Lifesciences Corp (NYSE:EW): Ranked #484 globally with a market cap of $44.54 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #79 | Abbott Laboratories | NYSE:ABT | $190.05 Billion | $109.95 |
| #169 | Medtronic PLC | NYSE:MDT | $112.92 Billion | $88.24 |
| #191 | Boston Scientific Corp | NYSE:BSX | $103.18 Billion | $69.79 |
| #484 | Edwards Lifesciences Corp | NYSE:EW | $44.54 Billion | $83.56 |
Stryker Corporation Historical Marketcap From 2015 to 2026
Between 2015 and today, Stryker Corporation's market cap moved from $32.16 Billion to $ 133.77 Billion, with a yearly change of 13.86%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $133.77 Billion | -0.54% |
| 2025 | $134.50 Billion | -2.38% |
| 2024 | $137.79 Billion | +21.06% |
| 2023 | $113.82 Billion | +23.80% |
| 2022 | $91.94 Billion | -7.42% |
| 2021 | $99.30 Billion | +10.22% |
| 2020 | $90.09 Billion | +18.17% |
| 2019 | $76.24 Billion | +35.33% |
| 2018 | $56.34 Billion | +2.43% |
| 2017 | $55.00 Billion | +30.84% |
| 2016 | $42.04 Billion | +30.69% |
| 2015 | $32.16 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 17th, 2026 the market cap of Stryker Corporation was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $133.77 Billion USD |
| MoneyControl | $133.77 Billion USD |
| MarketWatch | $133.77 Billion USD |
| marketcap.company | $133.77 Billion USD |
| Reuters | $133.77 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.